Response of hairy cells to IFN- (cid:1) involves induction of apoptosis through autocrine TNF- (cid:1) and protection by adhesion

Although hairy cell leukemia is uniquely sensitivetointerferon- (cid:1) (IFN- (cid:1) ),thebiologic basisforthisphenomenonremainsunclear. Here we examine the effects of IFN- (cid:1) on cultured hairy cells (HCs), taking into account the possible modifying influence of cell adhesion. We make the novel observa-tionthattherapeuticconcentrationsofIFN- (cid:1) kill nonadherent HCs by inducing apoptosis. In keeping with the persistence of HCs in tissues during therapy, such killing was inhibited by integrin-mediated adhesion to vitronectin or fibronectin. Exposure of HCs to IFN- (cid:1) resulted in a marked increase in tumor necrosis factor- (cid:1) (TNF- (cid:1) ) secretion. Furthermore, blocking antibodies to TNF-RI or TNF-RII protected HCs from IFN- (cid:1) – induced apoptosis, demonstrating that such killing was mediated by TNF- (cid:1) . In the absence of IFN- (cid:1) , exogenous TNF- (cid:1) did not induce HC apoptosis, showing that IFN- (cid:1) sensitized HCs to the proapoptotic effect of autocrine TNF- (cid:1) . This sensitization to TNF- (cid:1) –induced killing was at-tributabletosuppressionofIAP(inhibitors of apoptosis) production known to be regulated by the cytoprotective nuclear factor– (cid:2) B–dependent arm of TNF- (cid:1) signaling. Moreover, engagement of the receptors for fibronectin or vitronectin prevented this IFN- (cid:1) –induced down-regulation of IAPs. Understanding of the signals involved in the combined effects of IFN- (cid:1) and TNF- (cid:1) and abrogation of those induced by integrin engagement offers the possibility of sensitizing other malignant cells to IFN- (cid:1) –induced killing and thereby extending the therapeutic use ofthiscytokine.(Blood.2002;100:647-653)

[1]  A. López-Rivas,et al.  Interferon-γ Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism* , 2001, The Journal of Biological Chemistry.

[2]  K. Suk,et al.  IFNα sensitizes ME‐180 human cervical cancer cells to TNFα‐induced apoptosis by inhibiting cytoprotective NF‐κB activation , 2001 .

[3]  G. Kroemer [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.

[4]  S. Manna,et al.  IFN-α Suppresses Activation of Nuclear Transcription Factors NF-κB and Activator Protein 1 and Potentiates TNF-Induced Apoptosis1 , 2000, The Journal of Immunology.

[5]  E. Gardner,et al.  Age-related changes in interferon-α/β receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice , 2000, Mechanisms of Ageing and Development.

[6]  A. Pettitt,et al.  Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. , 2000, Cancer research.

[7]  R. Vakkalanka,et al.  Induction of Fas ligand-mediated apoptosis by interferon-alpha. , 2000, Clinical immunology.

[8]  G. Barber The interferons and cell death: guardians of the cell or accomplices of apoptosis? , 2000, Seminars in cancer biology.

[9]  L. Boise,et al.  Azidothymidine and Interferon-α Induce Apoptosis in Herpesvirus-associated Lymphomas , 1999 .

[10]  H. Tilg,et al.  Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. , 1999, Cytokine.

[11]  M. Reitz,et al.  Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. , 1999, Journal of immunology.

[12]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.

[13]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[14]  J. Dichgans,et al.  Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cells , 1998, Journal of Neuroimmunology.

[15]  M. Ormerod The study of apoptotic cells by flow cytometry , 1998, Leukemia.

[16]  N. Fausto,et al.  NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival , 1998, The Journal of cell biology.

[17]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[18]  R. Ravi,et al.  CD95 (Fas)-induced Caspase-mediated Proteolysis of NF-κB , 1998 .

[19]  G. Tell,et al.  Fibronectin Binding Promotes a PKC-Dependent Modulation of NF-κB in Human T Cells , 1998 .

[20]  R. Greil,et al.  Modulation of Apo‐1/Fas (CD95)‐induced programmed cell death in myeloma cells by interferon‐α2 , 1996, European journal of immunology.

[21]  R. Juliano,et al.  Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes. , 1996, Cancer research.

[22]  C. Billard,et al.  Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia. , 1995, Leukemia.

[23]  J. Burthem,et al.  Specific tissue invasion, localisation and matrix modification in hairy-cell leukemia. , 1994, Leukemia & lymphoma.

[24]  J. Burthem,et al.  The bone marrow fibrosis of hairy-cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells. , 1994, Blood.

[25]  J. Burthem Hairy cell adhesion and migration. , 1994 .

[26]  J. Burthem,et al.  Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins. , 1994, Blood.

[27]  N. Davidson,et al.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.

[28]  H. Heslop,et al.  Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders , 1990, The Journal of experimental medicine.

[29]  F. Sigaux,et al.  IFN-alpha in vivo enhances tumor necrosis factor receptor levels on hairy cells. , 1990, Journal of immunology.

[30]  B. Brownstein,et al.  B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens. , 1990, Cancer research.

[31]  H. Heslop,et al.  Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies. , 1988, Nouvelle revue francaise d'hematologie.

[32]  M. Hayashi,et al.  Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.

[33]  C. Worman,et al.  HAIRY‐CELL LEUKAEMIA , 1985, British journal of haematology.